Key structural requirements of benzamide derivatives for histone deacetylase inhibition: design, synthesis and biological evaluation
Future Medicinal Chemistry · 2024
DOI: 10.4155/fmc-2023-0122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Future Medicinal Chemistry, 2024. Verfasst von Narges Cheshmazar und 9 weiteren Autor:innen. Beteiligte Einrichtung: Biotechnology Research Center, Tabriz University of Medical Sciences, Tabriz, 5165665813, Iran. Hauptthemen laut MEDLINE: Histone Deacetylase Inhibitors, Benzamides, Drug Design, Cell Proliferation. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Biotechnology Research Center, Tabriz University of Medical Sciences, Research Office and Biotechnology Research Center of Tabriz University of Medical Sciences.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biotechnology Research Center, Tabriz University of Medical Sciences, Tabriz, 5165665813, Iran.
- Department of Medicinal Chemistry, School of Pharmacy, Tabriz University of Medical Sciences, Tabriz, 5166414766, Iran.
- Drug applied research Center, Tabriz University of Medical Sciences, Tabriz, 5165665811, Iran.
- Cellular & Molecular Research Center, Qom University of Medical Sciences, Qom, Iran.
- Department of Pharmacology, School of Medicine, Qom University of Medical Sciences, Qom, Iran.
- Anatomical Sciences Department, Faculty of Medicine, Tabriz University of Medical, Tabriz, 5166614766, Iran.
ORCID-Profile: Narges Cheshmazar, Maryam Hamzeh-Mivehroud, Salar Hemmati, Hoda Abolhasani, Fatemeh Heidari, Hojjatollah Nozad Charoudeh, Mike Schutkowski, Wolfgang Sippl, Siavoush Dastmalchi
Förderung
- Biotechnology Research Center, Tabriz University of Medical Sciences
- Research Office and Biotechnology Research Center of Tabriz University of Medical Sciences
Zitieren
APA
Cheshmazar, N., Hamzeh-Mivehroud, M., Hemmati, S., Abolhasani, H., Heidari, F., Charoudeh, H. N., Zessin, M., Schutkowski, M., Sippl, W., & Dastmalchi, S. (2024). Key structural requirements of benzamide derivatives for histone deacetylase inhibition: design, synthesis and biological evaluation. Future Medicinal Chemistry. https://doi.org/10.4155/fmc-2023-0122
Vancouver
Cheshmazar N, Hamzeh-Mivehroud M, Hemmati S, Abolhasani H, Heidari F, Charoudeh HN, et al. Key structural requirements of benzamide derivatives for histone deacetylase inhibition: design, synthesis and biological evaluation. Future Medicinal Chemistry. 2024. doi:10.4155/fmc-2023-0122
BibTeX
@article{Cheshmazar2024,
author = {Cheshmazar, Narges and Hamzeh-Mivehroud, Maryam and Hemmati, Salar and Abolhasani, Hoda and Heidari, Fatemeh and Charoudeh, Hojjatollah Nozad and Zessin, Matthes and Schutkowski, Mike and Sippl, Wolfgang and Dastmalchi, Siavoush},
title = {Key structural requirements of benzamide derivatives for histone deacetylase inhibition: design, synthesis and biological evaluation},
journal = {Future Medicinal Chemistry},
year = {2024},
doi = {10.4155/fmc-2023-0122}
}
EUVIMED